SCHEMBL19022011

SCHEMBL19022011

CCNC(=O)CC1CCCN(C)C1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.42
NFE2L2 Q16236 2/20 0.42
BCHE P06276 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPK1 P28482 1/20 0.40
SIGMAR1 Q99720 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GFER P55789 1/20 0.36
OPRD1 P41143 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 2/20 0.36
HPGD P15428 2/20 0.36
EPHX1 P07099 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19022015 0.90 KEAP1 (0.41) KEAP1NFE2L2BCHEALDH1A1MAPK1
SCHEMBL26343670 0.87 KEAP1 (0.46) KEAP1NFE2L2ALDH1A1SIGMAR1SMN1; SMN2
SCHEMBL19022017 0.84 KMT2A (0.38) KEAP1NFE2L2BCHESMN1; SMN2KMT2A
SCHEMBL19010255 0.83 SMN1; SMN2 (0.41) KEAP1NFE2L2BCHESIGMAR1SMN1; SMN2
SCHEMBL18502529 0.81 POLB (0.46) KEAP1NFE2L2SIGMAR1SMN1; SMN2GFER
SCHEMBL20673395 0.81 SMN1; SMN2 (0.40) KEAP1NFE2L2ALDH1A1SIGMAR1SMN1; SMN2
SCHEMBL10274873 0.81 KEAP1 (0.48) KEAP1NFE2L2BCHESIGMAR1KMT2A
SCHEMBL19000034 0.80 SMN1; SMN2 (0.42) KEAP1NFE2L2SIGMAR1SMN1; SMN2GFER
SCHEMBL10170261 0.80 HPGD (0.53) KEAP1NFE2L2SMN1; SMN2KMT2AHPGD
SCHEMBL2607208 0.78 SMN1; SMN2 (0.45) ALDH1A1SMN1; SMN2GFERCHRNB2CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017106607-A1 POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS MERCK PATENT GMBH (DE) 2017-06-22 WO disclosed